blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1581227

EP1581227 - A METHOD FOR TREATING RENAL FAILURE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.01.2008
Database last updated on 06.07.2024
Most recent event   Tooltip04.01.2008No opposition filed within time limitpublished on 06.02.2008  [2008/06]
Applicant(s)For all designated states
ORION CORPORATION
Orionintie 1
02200 Espoo / FI
[2007/16]
Former [2005/40]For all designated states
Orion Corporation
Orionintie 1
02200 Espoo / FI
Inventor(s)01 / KIVIKKO, Matti
Isokaari 8 A 20
FIN-00200 Helsinki / FI
02 / HAIKALA, Heimo
Seilimäki 18 A 4
FIN-02180 Espoo / FI
 [2005/40]
Representative(s)Sexton, Jane Helen
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2007/09]Sexton, Jane Helen
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Former [2005/40]Sexton, Jane Helen
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date04700048.402.01.2004
[2005/40]
WO2004FI00002
Priority number, dateFI2003000001503.01.2003         Original published format: FI 20030015
[2005/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004060375
Date:22.07.2004
Language:EN
[2004/30]
Type: A1 Application with search report 
No.:EP1581227
Date:05.10.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 22.07.2004 takes the place of the publication of the European patent application.
[2005/40]
Type: B1 Patent specification 
No.:EP1581227
Date:28.02.2007
Language:EN
[2007/09]
Search report(s)International search report - published on:EP22.07.2004
ClassificationIPC:A61K31/50, A61P13/12
[2005/40]
CPC:
A61K31/50 (EP,US); A61P13/00 (EP); A61P13/12 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/40]
Extension statesAL21.07.2005
LT21.07.2005
LV21.07.2005
MK21.07.2005
TitleGerman:METHODE ZUR BEHANDLUNG VON NIERENINSUFFIZIENZ[2005/40]
English:A METHOD FOR TREATING RENAL FAILURE[2005/40]
French:PROCEDE POUR TRAITER L'INSUFFISANCE RENALE[2005/40]
Entry into regional phase21.07.2005National basic fee paid 
21.07.2005Designation fee(s) paid 
21.07.2005Examination fee paid 
Examination procedure30.07.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.07.2005Examination requested  [2005/40]
31.01.2006Despatch of a communication from the examining division (Time limit: M04)
08.05.2006Reply to a communication from the examining division
04.07.2006Communication of intention to grant the patent
30.10.2006Fee for grant paid
30.10.2006Fee for publishing/printing paid
Opposition(s)29.11.2007No opposition filed within time limit [2008/06]
Fees paidRenewal fee
12.01.2006Renewal fee patent year 03
12.01.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]JPH04368328  ;
 [AD]EP0565546  (ORION YHTYMAE OY [FI]) [AD] 1-4,1-4,1-4 * the whole document * * the whole document * * the whole document *;
 [A]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 1993, no. 14, Database accession no. 1993-111711, XP002283338 & JPH04368328 A 19921221 (TEIKOKU HORMONE MFG CO LTD) [A] 1-4,1-4,1-4 * abstract * * abstract * * abstract *
 [A]  - PAGEL P S ET AL, "PHARMACOLOGY OF LEVOSIMENDAN: A NEW MYOFILAMENT CALCIUM SENSITIZER", CARDIOVASCULAR DRUG REVIEWS, NEVA PRESS, BRANFORD, CT, US, (1996), vol. 14, no. 3, ISSN 0897-5957, pages 286 - 316, XP008030915 [A] 1-4,1-4,1-4 * the whole document * * the whole document * * the whole document *
 [A]  - PAGEL P S HETTRICK D A ET AL, INFLUENCE OF LEVOSIMENDAN PIMOBENDAN, AND MILRINONE ON THE REGIONAL DISTRIBUTION OF CARDIAC OUTPUT IN ANAESTHETIZED DOGS, BRITISH JOURNAL OF PHARMACOLOGY, BASINGSTOKE, HANTS, GB, PAGE(S) 609-615, (1996), ISSN 0007-1188, XP002901958 [A] 1-4,1-4,1-4 * abstract * * page 611, column 1, paragraph 3 * * abstract * * page 611, column 1, paragraph 3 * * abstract * * page 611, column 1, paragraph 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.